Dose-finding design and benchmark for a right censored endpoint.

Journal of Biopharmaceutical Statistics
Anaïs AndrillonLucie Biard

Abstract

Dose-finding trials aim to determine a safe dose to be tested in larger trials for efficacy. In oncology, designs generally assume conventional monotonic increasing dose-toxicity relationships, mostly with binary outcomes (e.g., dose-limiting toxicity or not), measured in the first cycle of therapy or for a fixed number of cycles. However, with new anti-cancer agents such as molecularly targeted therapies and immunotherapies, late-onset toxicities have become more frequent. Designs with prolonged observation windows and censored endpoints analyzed using survival models, appear particularly suited to these settings. Moreover, in this setting, the observation of the late-onset toxicity endpoint could be precluded by trial discontinuation due to death, progression, patient withdrawal, or physician discretion, defining a competing event to toxicity. We propose extensions of the Continual Reassessment Method (CRM) dose-finding design using survival working models for right-censored endpoints and for handling treatment discontinuation in the toxicity observation window, namely the Survival-CRM (Surv-CRM) and the informative survival-CRM (iSurv-CRM). We also developed a benchmark approach for its evaluation. In a simulation study, we ...Continue Reading

References

Aug 23, 2003·Biostatistics·John O'QuigleyJean Maccario
Oct 13, 2006·Statistics in Medicine·H PutterR B Geskus
Jan 7, 2009·Statistics in Medicine·Jan BeyersmannMartin Schumacher
Jun 17, 2009·Clinical Trials : Journal of the Society for Clinical Trials·Shing M Lee, Ying Kuen Cheung
Mar 30, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sophie Postel-VinayXavier Paoletti
Feb 28, 2014·Biometrics·Ying Kuen Cheung
Mar 26, 2014·Nature Reviews. Clinical Oncology·Ron H J MathijssenJaap Verweij
Mar 2, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shing M LeeLori Minasian
Nov 16, 2017·Biostatistics·Shing M LeeSarah Zohar
Jun 9, 2018·Pharmaceutical Statistics·Beibei GuoYing Yuan
Aug 24, 2018·Journal for Immunotherapy of Cancer·Nolan A WagesKatherine S Panageas
Aug 31, 2018·Biostatistics·Pavel MozgunovXavier Paoletti
Jan 20, 2019·BMC Medical Research Methodology·Graham M WheelerSimon J Bond
Mar 19, 2019·Journal of the Royal Statistical Society. Series C, Applied Statistics·Graham M WheelerAdrian P Mander
Sep 16, 2020·Journal of Biopharmaceutical Statistics·Lucie BiardShing M Lee

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Software Mentioned

iSurv
CRM
Surv
TITE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.